近5年高被引文献
The 2022 hormone therapy position statement of The North American Menopause Society
article
Full Text
OpenAlex
766
FWCI88.1565
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
article
Full Text
OpenAlex
342
FWCI34.1278
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
review
Full Text
OpenAlex
321
FWCI95.1241
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
article
Full Text
OpenAlex
300
FWCI42.922
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
article
Full Text
OpenAlex
293
FWCI49.5921
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
review
Full Text
OpenAlex
285
FWCI45.513
Menopause transition: Physiology and symptoms
review
Full Text
OpenAlex
276
FWCI32.1153
Role of estrogen receptors in health and disease
review
Full Text
OpenAlex
267
FWCI43.6225
The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions
review
Full Text
OpenAlex
267
FWCI70.6354
Sex hormone signaling and regulation of immune function
review
Full Text
OpenAlex
260
FWCI73.2761